Stay updated with breaking news from Sciences Profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
National Bank of Canada FI purchased a new stake in Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) in the 4th quarter, HoldingsChannel reports. The fund purchased 511,238 shares of the biopharmaceutical company’s stock, valued at approximately $37,114,000. Several other hedge funds also recently modified their holdings of the company. Morgan Stanley boosted its position in […]
Jacobs & Co. CA trimmed its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 15.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 23,689 shares of the biopharmaceutical company’s stock after selling 4,400 shares during the period. Jacobs & […]
Pinnacle Wealth Management Advisory Group LLC raised its position in Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 7.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 13,910 shares of the biopharmaceutical company’s stock after purchasing an additional 907 shares during the period. Pinnacle […]
Stratos Wealth Advisors LLC trimmed its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 7.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,656 shares of the biopharmaceutical company’s stock after selling 387 shares during […]
IVC Wealth Advisors LLC lifted its stake in shares of Cassava Sciences, Inc. (NASDAQ:SAVA – Get Rating) by 27.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 12,575 shares of the company’s stock after purchasing an additional 2,700 shares during […]